Internal Medicine Gamechangers (NON-COVID Edition), Winter 2022

January 19, 2022


Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public or the profession.

Target Audience

Physicians, Advance Practice Professionals, Nurses, Ancillary Staff, Medical Students (Rotating), Non-Medical Students (Rotating), and Healthcare Administrators.

Learning Objectives

  • Describe the role of methylprednisolone in out of hospital cardiac arrest.
  • Apply the 2021 ACG guidelines on GERD to a specific patient 
  • Disucss the Nocebo effect and its role in statin adverse reactions.
  • Describe the role of the SGLT2 drugs in treating HFrEF and HFpEF.
  • Compare and contrast current use of PPI drips with new guidelines.
  • Describe a plan to deescalate use of ICSs in COPD patients when appropriate.
Course summary
Available credit: 
  • 1.00 AOA Category 1­B
Course opens: 
Course expires: 
Event starts: 
01/19/2022 - 12:00pm CST
Event ends: 
01/19/2022 - 1:00pm CST

Geoffrey C. Wall, PharmD, FCCP, BCPS
Ellis Distinguished Professor of Pharmacy Practice, Drake University
Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center


Accreditation Statements

  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.


No ineligible company provided financial support for this continuing education activity.


Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any ineligible company. The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose:

  • Geoffrey C. Wall, PharmD, FCCP, BCPS, Speaker, is a speaker’s bureau member for Janssen and La Jolla Pharmaceuticals and intends to discuss off-label use of medication during this educational activity.

CME Committee

  • No member of the Mary Greeley Medical Center CME Committee who planned this activity has any financial relationship to disclose relating to the content. 

This program is supported by gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, Availa Bank, and Green Hills Health Care Center. The content and selection of speaker(s) is the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee and not the sponsors of this program.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AOA Category 1­B


Please login or Create an Account to take this course.